ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconIcon FacebookIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Health Technology

CYBERDYNE, Inc.

  • 858.00 JPY
  • +29.00
  • +3.50%
  • Japan
    Nov 16, 2018
  • Ticker
    TKS(7779)
  • Prev. close
    829
  • Market cap (JPY)
    178,274.47M
  • Market cap (USD)
    1,572.22M
  • Shares
    215.04M

Business Summary

CYBERDYNE, Inc. engages in the research and development of medical welfare equipment and systems. It develops technology for rehabilitation support, body function support in elderly and disabled people, rescue support in disaster sites, and heavy labor support in factories. The company was founded by Dr. Yoshiyuki Sankai on June 24, 2004 and is headquartered in Tsukuba, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue1,728M15.59M
Gross Profit1,066M9.61M
Operating income-1,018M-9.18M
Income before tax-672M-6.06M
Net income-673M-6.07M
EBITDA-619M-5.58M
Diluted EPS-3.13-0.02
Dividends Per Share00
Total Assets46,598M438.15M
Total liabilities924M8.68M
Total equity45,698M429.69M
Operating cash flow-53M-0.47M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 456.37M 631.27M 1,264.90M 1,660M 1,728M
Gross Profit 133.19M 198.63M 761.70M 950M 1,066M
Operating income -1,154.24M -1,766.11M -1,292.13M -1,189M -1,018M
Income before tax -678.55M -902.89M -710.07M -648M -672M
Net income -688.17M -915.89M -718.05M -676M -673M
EBITDA -974.57M -1,563.82M -1,011.83M -854M -619M
Diluted EPS -3.94 -4.74 -3.53 -3.16 -3.13
Dividends Per Share 0 0 0 0 0
Total Assets 6,434.76M 48,289.05M 47,534.47M 47,712M 46,598M
Total liabilities 438.94M 20,511.75M 20,470.53M 976M 924M
Total equity 5,995.82M 27,774.66M 27,063.93M 46,768M 45,698M
Operating cash flow -539.58M -779.28M -258.28M 575M -53M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 4.55M 5.74M 10.53M 15.32M 15.59M
Gross Profit 1.32M 1.80M 6.34M 8.77M 9.61M
Operating income -11.52M -16.07M -10.76M -10.98M -9.18M
Income before tax -6.77M -8.21M -5.91M -5.98M -6.06M
Net income -6.86M -8.33M -5.97M -6.24M -6.07M
EBITDA -9.72M -14.23M -8.42M -7.88M -5.58M
Diluted EPS -0.03 -0.04 -0.02 -0.02 -0.02
Dividends Per Share 0 0 0 0 0
Total Assets 62.48M 402.66M 422.92M 428.17M 438.15M
Total liabilities 4.26M 171.03M 182.13M 8.75M 8.68M
Total equity 58.22M 231.60M 240.79M 419.70M 429.69M
Operating cash flow -5.38M -7.09M -2.15M 5.30M -0.47M

Valuation Measures

Mar 2018
PER--
ROA-1.42%
ROE-1.45%
Operating margin-58.91%
Profit margin-38.94%

Key executives

  • President & Representative Director: Yoshiyuki Sankai
  • Director & Team Leader-Information Strategy: Fumiyuki Ichihashi
  • Director: Shinji Uga

Shareholders

  • Daiwa House Industry Co., Ltd. (21.8%)
  • Capital International KK (2.4%)
  • Global X Management Co. LLC (2.2%)
  • SANKAI YOSHIYUKI (2.2%)
  • Shiozumi Asset Management Co. Ltd. (1.6%)
  • Credit Suisse Asset Management (Schweiz) AG (1.0%)
  • BlackRock Fund Advisors (1.0%)
  • Jennison Associates LLC (0.7%)
  • Capital International Ltd. (0.5%)
  • Matthews International Capital Management LLC (0.5%)

Contact Details

Related Companies

  • CEJ Capital, Inc.
  • Niigata Robo Care Center Co., Ltd.
  • CYBERDYNE USA Inc.
  • Oita Robo Care Center KK
  • Shonan Robo Care Center KK
  • Suzuka Robo Care Center KK
  • Cyberdyne Care Robotics GmbH
  • CYBERDYNE Europe GmbH
  • Cyberdyne Sweden AB
  • Cyberdyne Denmark ApS
  • Cyberdyne EU BV

Competitors

  • ReWalk Robotics Ltd.
  • Ekso Bionics Holdings, Inc.
Last Updated on 16 Nov, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media